Welcome to Empiriko

Empiriko is a clinical intelligence technology company that is developing the next generation of innovative solutions for integrating structured and unstructured data from disparate systems, then analyzing and predicting outcomes throughout drug discovery, clinical development, post-market research and patient care. Empiriko technology enables key stakeholders to exchange critical information from bedside-to-bench-and-back, in order to continuously learn and leverage knowledge from experiential data. The company’s proprietary predictive modeling engine incorporates disease, population/patient and drug modeling -- and combines sophisticated statistical algorithms, analytics and simulation methodologies -- providing an innovative vehicle for:

• Accelerating clinical trials through optimized study design, simulation and predictive modeling
• Automating and standardizing clinical trial data analysis for regulatory submissions
• Enabling cross-trial analysis of historical trial data to help design effective clinical trials on new compounds
• Automating the regulatory submission process by eliminating manual compilation of various data sets and streamlining required documentation
• Determining the appropriateness and effectiveness of drugs for specific patient populations via outcomes research
• Sharing critical information about safety, efficacy, toxicity, pharmacokinetics and pharmacodynamics with key stakeholders
• Optimizing leads among promising candidates and eliminating riskier candidates early-on to reduce late stage attrition rates

With Empiriko clinical intelligence technology, researchers and clinicians can apply a new level of proactive intelligence – aimed at designing better compounds and clinical studies, and treating patients more effectively.